表紙
市場調查報告書
商品編碼
1002621

基因學市場:現狀分析與預測(2021年∼2027年)

Genomics Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 289 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

基因組學是一個涉及許多不同學科的廣闊科學領域,其重點是充分了解生物體DNA的工作方式(其結構,功能以及如何定位),並最終可以對其進行修飾。著眼於單個基因和世代相傳的過程,而基因組學則著眼於整個DNA結構和基因的完整集合。當前,遺傳學對醫學實踐極為重要,因為提供許多臨床上的異質性疾病明確的診斷。因此,可以實現更精確的疾病預後,並為受影響患者的最佳治療選擇提供指導。目前,大部分來自於從染色體到單鹼基變化等各個階段檢查人類基因組的能力。

全球基因學市場,2020年為213億1260萬美金,預計從2021年到2027年以15.10%的年複合成長率大幅擴大。全球基因學市場,由於序列成本的削減,在各種領域的基因學的應用,政府的基因學計劃的資金提供和配合措施增加等預計成長。

本報告提供全球基因學市場調查,市場概要,新型冠狀病毒感染疾病(COVID-19)的影響,各產品、服務、技術、應用、終端用戶、地區的市場規模的變化與預測,收益,成長率,市場成長要素及課題,市場機會,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 調查手法、前提條件

  • 市場調查手法

第3章 市場概要

第4章 摘要整理

第5章 基因學資料策略

第6章 新型冠狀病毒感染疾病(COVID-19)旋渦之中的基因學

第7章 全球基因學市場收益

第8章 市場洞察:各產品、服務

  • 消耗品
  • 系統軟體
  • 服務

第9章 市場洞察:各技術

  • 序列
  • 聚合酵素鏈鎖反應(PCR)
  • 核酸開採、精製
  • 微陣列
  • 其他

第10章 市場洞察:各應用領域

  • 診斷
  • 藥物研發、開發
  • 個人化醫療
  • 農業、動物研究
  • 其他

第11章 市場洞察:各終端用戶

  • 製藥、生物科技企業
  • 醫院、診療所
  • 學術機構、政府機關
  • 臨床研究機關
  • 其他

第12章 市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 其他地區

第13章 市場動態

  • 市場推動因素
  • 市場課題
  • 影響分析

第14章 市場機會

第15章 市場趨勢

第16章 相關法規

第17章 需求與供給側面分析

  • 需求端分析
  • 供應端分析

第18章 價值鏈分析

第19章 企業概要

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F Hoffmann-La Roche
  • Illumina
  • Myriad Genetics
  • Oxford Nanopore Technologies
  • QIAGEN
  • Thermo Fisher Scientific
  • BGI Genomics

第20章 免責聲明

目錄
Product Code: UMHE21218

Genomics is a vast field of science involving many different disciplines with the focus on fully understanding how an organism's DNA works (its structure, function(s) and how they are mapped) and can eventually be modified. It looks at individual genes and the passage process through generations whereas genomics is looking at the entire DNA structure and complete set of gene. Currently genetics is of extreme importance to medical practice as it provides a definitive diagnosis for many clinically heterogeneous diseases. Consequently, it enables a more precise disease prognosis and provides guidance towards the selection of the best therapeutic choices for the affected patients. Much of its current promise comes from its ability to examine the human genome at various stages, from chromosome to single-base changes.

The study of genomics is receiving immense attention from investors as well as from the public as it impacts the very core of the lives and all living things around globe. Completing the sequencing of the first human genome in 2003 was a key breakthrough that took over 10 years and cost approximately USD 3 billion. Since then, the sequencing speed of a genome has more than doubled, significantly outpacing Moore's Law. Today's high throughput sequencing machines process the human genome in a matter of hours at a cost approaching USD 1,000. These advancements have allowed researchers to run more genome analysis in less time, greatly increasing the pace of scientific discovery.

Based on product/services, the market is fragmented into consumables, systems and software, and services. The consumables segment generated revenue of USD 11,495.7 million in 2020. The market is expected to grow at a CAGR of 14.27% during the forecast period to reach a market valuation of USD 29,355.3 million by 2027F owing to the increasing demand of the reagents, sampling, and sequencing process of the genomes.

Based on technology, the market is bifurcated into sequencing, polymerase chain reaction, nucleic acid extraction and purification, microarray, and others. The sequencing segment generated revenue of USD 8,388.6 million in 2020. The market is expected to grow at a CAGR of 15.27% during the forecast period to reach a market valuation of USD 22,759.9 million by 2027F. Based on the application, the market is fragmented into diagnostics, drug discovery and development, personalized medicine, agriculture & animal research, and others. The diagnostics segment dominated the market and generated revenue of USD 6,848.6 million in 2020. However, personalized medicine is anticipated to grow at highest CAGR during the forecast period and reach USD 11,001.3 million by 2027F.

The genomics research and development and utilization are available at various centers including pharmaceutical & biotechnology companies, hospitals and clinics, academic & government institutes, clinical research, and others. The pharmaceutical & biotechnology companies are anticipated to dominate the market during the analyzed period and reach USD 33,850.6 million by 2027F. However, the hospitals & clinics segment is expected to grow at the highest CAGR throughout the forecast period 2021-2027F.

For a better understanding of the market adoption of the Genomics market, the market is analyzed based on its worldwide presence in the countries such as North America (United States and Canada), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. North America constitutes a major market for the Genomics industry and generated revenue of USD 8,982.8 million in 2020 owing to the increasing incidence of cancer and other diseases, rising healthcare spending and increasing government initiatives in the region.

Some of the major players operating in the market include: Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, BGI, Danaher Corporation, Myriad Genetics, and Oxford Nanopore Technologies. Several M&A's along with partnerships have been undertaken by these players to develop Genomics.

The global Genomics market was valued at USD 21,312.6 million in 2020 and is projected to expand significantly with a CAGR of 15.10% from 2021 to 2027F. The market is expected to witness a boost owing to the reduced sequencing costs, genomics application in varied segments and rising government funding and initiatives in the genomic projects.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Genomics Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Genomics Market
    • 2.1.1 Main Objective of the Global Genomics Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GENOMICS DATA STRATEGIES

6 GENOMICS AMID COVID-19

7 GLOBAL GENOMICS MARKET REVENUE (USD MN), 2019-2027F

8 MARKET INSIGHTS BY PRODUCT/SERVICES

  • 8.1 Consumables
  • 8.2 Systems and Software
  • 8.3 Services

9 MARKET INSIGHTS BY TECHNOLOGY

  • 9.1 Sequencing
  • 9.2 Polymerase Chain Reaction (PCR)
  • 9.3 Nucleic Acid Extraction and Purification
  • 9.4 Microarray
  • 9.5 Others

10 MARKET INSIGHTS BY APPLICATION

  • 10.1 Diagnostics
  • 10.2 Drug Discovery and Development
  • 10.3 Personalized Medicine
  • 10.4 Agriculture & Animal Research
  • 10.5 Others

11 MARKET INSIGHTS BY END-USER

  • 11.1 Pharmaceutical & Biotechnology Companies
  • 11.2 Hospitals & Clinics
  • 11.3 Academic & Government Institutes
  • 11.4 Clinical Research
  • 11.5 Others

12 MARKET INSIGHTS BY REGION

  • 12.1 North America Genomics Market
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Rest of North America
  • 12.2 Europe Genomics Market
    • 12.2.1 Germany
    • 12.2.2 France
    • 12.2.3 United Kingdom
    • 12.2.4 Italy
    • 12.2.5 Spain
    • 12.2.6 Rest of Europe
  • 12.3 Asia Pacific Genomics Market
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 Rest of Asia Pacific
  • 12.4 Rest of World Genomics Market

13 GENOMICS MARKET DYNAMICS

  • 13.1 Market Drivers
  • 13.2 Market Challenges
  • 13.3 Impact Analysis

14 GENOMICS MARKET OPPORTUNITIES

15 GENOMICS MARKET TRENDS

16 LEGAL & REGULATORY FRAMEWORK

17 DEMAND AND SUPPLY SIDE ANALYSIS

  • 17.1 Demand Side Analysis
  • 17.2 Supply Side Analysis
    • 17.2.1 Top Product Launches
    • 17.2.2 Top Business Partnerships
    • 17.2.3 Top Business Expansions, Investments and Divestitures
    • 17.2.4 Top Merger and Acquisitions

18 VALUE CHAIN ANALYSIS

19 COMPANY PROFILED

  • 19.1 Agilent Technologies
  • 19.2 Bio-Rad Laboratories
  • 19.3 Danaher Corporation
  • 19.4 F Hoffmann-La Roche
  • 19.5 Illumina
  • 19.6 Myriad Genetics
  • 19.7 Oxford Nanopore Technologies
  • 19.8 QIAGEN
  • 19.9 Thermo Fisher Scientific
  • 19.10 BGI Genomics

20 DISCLAIMER